ACER THERAPEUTICS INC. Restricted Stock or Unit Expense
ACER THERAPEUTICS INC. reported Restricted Stock or Unit Expense of $66.96 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2015-11-10
- ACER THERAPEUTICS INC. restricted stock or unit expense for the quarter ending 2015-09-30 was $11.25K, a 76.82% decline year-over-year.
- ACER THERAPEUTICS INC. restricted stock or unit expense for the quarter ending 2015-06-30 was $11.25K, a 78.89% decline year-over-year.
- ACER THERAPEUTICS INC. restricted stock or unit expense for the quarter ending 2015-03-31 was $44.46K, a 55.62% decline year-over-year.
- ACER THERAPEUTICS INC. restricted stock or unit expense for the quarter ending 2014-09-30 was $48.53K.
| Period end | Restricted Stock or Unit Expense 3 month | Restricted Stock or Unit Expense 6 month | Restricted Stock or Unit Expense 9 month | Restricted Stock or Unit Expense 134 month |
|---|---|---|---|---|
| 2015-09-30 | $11.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $22.50K derived: sum of 2 quarters · filed 2015-11-10 | $66.96K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $11.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $55.71K 10-Q · filed 2015-08-12 | ||
| 2015-03-31 | $44.46K 10-Q · filed 2015-05-12 | |||
| 2014-09-30 | $48.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $101.82K derived: sum of 2 quarters · filed 2015-11-10 | $202.00K 10-Q · filed 2015-11-10 | |
| 2014-06-30 | $53.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $153.47K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $100.18K 10-Q · filed 2015-05-12 | $238.64K 10-Q · filed 2014-05-14 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $0.00 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 |